Regulatory Perspective on Microbial Biopesticides in Canada:

Winnipeg’s summers are marked by mosquitoes so persistent they could say hello by name. Homeowners here worry about fleas on pets and ants in the kitchen as soon as the snow melts. In this cold-weather corner of Canada, pest season is short but intense. Instead of reaching for harsh chemicals, many prairie homesteads and city gardens are turning to microbial biopesticides, living bacteria or fungi that fight pests. Our pest control efforts (and mistakes) require not only effective products but also those proven to be safe. This brings us to the role of Canada’s Pest Management Regulatory Agency (PMRA) in assessing microbial pesticides. In this article, we explain the Canadian regulatory framework for microbial biopesticides, the innovative pesticide risk assessment methods PMRA is adopting, and why transparency in regulation is becoming more important. We’ll also include some Manitoba humour because, whether it’s a bedbug in July or a policy review in Ottawa, a bit of wit never hurts.

Microbial Biopesticides 101

Microbial biopesticides are pest control products whose active ingredients are microorganisms (bacteria, fungi, viruses, or protozoa) or their natural products (toxins or spores). Compared to synthetic chemicals, they tend to be very target-specific and leave fewer residues in the environment: a selling point for eco-conscious Winnipeggers. Canada was actually an early adopter of biopesticides: the first registered Canadian bioinsecticide was Bacillus thuringiensis (Bt) in 1972. (Winnipeg gardeners might recognize Bt products used against caterpillars or mosquitoes.) Other firsts included Agrobacterium radiobacter (the first bacterial biocontrol in 1989) and Streptomyces griseoviridis (first fungal biofungicide in 1999). Altogether, by 2008 the PMRA had approved 24 microbial active substances with 83 product formulations, with over half of those registrations occurring since 2000.

Key Biopesticides Registered in Canada: Bacillus thuringiensis (1972, first bioinsecticide); Agrobacterium radiobacter (1989, first bacterial biocontrol); Colletotrichum gloeosporioides f.sp. malvae (1992, first bioherbicide); Streptomyces griseoviridis (1999, first biofungicide); and many others. (Common fungal agents like Beauveria bassiana are also commercially used against insects in Canada, though not specifically cited here.)

Globally, microbial pesticides are on the rise while traditional chemical pesticide use declines. North America alone accounts for about 44% of the biopesticide market share. Growth rates hover around 10% per year, though regulatory hurdles and public attitudes can slow adoption. In Canada, new legislation and policy changes in the last two decades have “spurred momentum” for microbial pest-control products. For example, federal initiatives have streamlined registration for lower-risk products and encouraged innovation in biocontrol. The result is a Canadian “model system” for biopesticide development that other countries look to. Winnipeg homeowners may not follow Ottawa’s policy bulletins, but the impacts trickle down: more options and safer tools are on the shelf for our spring and summer pest battles.

Canadian Regulatory Framework (PMRA and Pest Control Products Act)

All pesticides in Canada, chemical or microbial, fall under the Pest Control Products Act (PCPA), which is administered by Health Canada’s Pest Management Regulatory Agency (PMRA). In practice, this means PMRA registers any pest control product (often called a pest control product or “pesticide” in Canada) only after a stringent, science-based risk assessment. Registrations are not “lifetime” deals: PMRA also conducts mandatory re-evaluations of older products on a cycle (usually every 15 years) to check that current science still supports their safe use. Essentially, PMRA acts like a super-strict home inspector for pesticides, asking to see all data on safety for humans, animals, and the environment.

According to Bhuller et al. (2021), “Health Canada’s PMRA is responsible for pesticide regulation in Canada”. That includes reviewing laboratory and field studies on toxicity, environmental fate, residue levels, and so on, for each proposed product. For microbial biopesticides, the risk assessment considers not only the microbe’s potency, but its host range (which insects or weeds it kills), potential to infect non-target species, and whether it produces toxins. These data requirements can be extensive; historically, Canadian regulatory submissions have relied on long checklists of standardized animal and ecotoxicity tests. For example, a new microbial insecticide might need mammalian toxicity studies and tests on fish, birds, and beneficial insects to ensure safety.

Importantly, PMRA’s framework is built to be flexible. Under the Act, PMRA can accept data from “a wide variety of published and unpublished sources”. The law also allows PMRA to update its rules and require new kinds of data as science advances. Recent PMRA annual reports highlight a “major transformation” of the pesticides program. This transformation means blending modern science and data analysis into the review process. In practice, PMRA is increasingly encouraging approaches beyond the old animal-testing paradigm, as we discuss below under next-generation risk assessment.

To summarize this section: The PMRA ensures pesticides (microbial or not) are safe through risk assessments. These rely on laws and guidance documents that spell out data requirements, but those rules are agile. PMRA can update requirements and engage stakeholders (industry, scientists, public) whenever major changes are proposed. Recent strategy documents emphasize transparency and collaboration in developing new guidance, aligning with the Agency’s stated goal of building public confidence in its science-based process.

Next-Generation Pesticide Risk Assessment

Modern biological insights are reshaping pesticide risk assessment. The term “next-generation risk assessment” refers to using advanced science – like computational models, cell-based tests, and mechanistic data – rather than solely relying on outdated animal tests. In Canada, PMRA and other parts of Health Canada have begun adopting these New Approach Methodologies (NAMs) and integrated strategies. Bhuller et al. describe how Canada has embraced integrated testing and assessment (IATA), adverse outcome pathways (AOPs), and NAMs in the past decade. The idea is to streamline testing using, for example, a series of in vitro (cellular) assays that predict toxicity, and computer models that estimate chemical hazards from structure, instead of many animal studies.

For pesticides, which tend to be “data-rich” chemicals (meaning a lot of study data are submitted), PMRA still requires many traditional tests. But even here alternative methods are creeping in. As Bhuller et al. note: “The regulatory submissions rely on a prescribed list of data requirements that include several animal studies and often comprise in silico (QSAR), in vitro assays, and more recently NAMs (e.g., defined approaches for skin sensitization).” In plain language, along with the usual toxicity studies, applicants can now submit computer modeling results and lab-based toxicity screens for certain endpoints. When these are “equally or better suited,” PMRA may waive some animal tests. For example, a predictive computer model (QSAR) might flag that a new microbial toxin isn’t likely to cause skin allergies, allowing PMRA to skip an animal test for sensitization.

Beyond these examples, Health Canada’s chemical safety programs are actively building case studies to prove new methods work. Bhuller et al. mention that integrated approaches for endocrine disruption, for instance, use a weight-of-evidence framework: compiling traditional data, NAMs, and published literature together to make a call on risk. Transcriptomic profiling (measuring genome-wide gene expression in cells exposed to a substance) has even been used to find toxic effect thresholds in chemical reviews. In one case, transcriptomics helped identify points-of-departure for risk by showing what dose caused significant biological change – and that data were “protective of human health” when compared to conventional endpoints.

Examples of Next-Gen Methods:

1. QSAR (In Silico Models): Computer algorithms predict toxicity from chemical structure. Canada’s programs have developed and validated QSAR tools for many pesticide-relevant endpoints.
2. Defined Approaches: Standardized sets of lab tests (often in vitro) that collectively assess things like skin sensitization or genetic toxicity. For instance, OECD-endorsed “defined approaches” are used to avoid animal testing for skin allergy.
3. Omics & ToxCast Data: High-throughput screens (like US EPA’s ToxCast) test thousands of chemicals in many cell assays. Health Canada’s case studies show these data can derive points of departure for risk assessment. Similarly, transcriptomics (gene expression assays) have been piloted to identify hazard thresholds.
4. Adverse Outcome Pathways (AOPs): Conceptual models linking molecular events to adverse effects. PMRA scientists reference AOPs in its integrated strategy for next-gen assessments.

These approaches are all about evidence integration. Rather than a simple pass/fail checklist of tests, PMRA is moving toward using multiple lines of evidence (tox study data, alternative test results, mechanistic info) in a holistic weight-of-evidence (WoE) framework. The hope is that, over time, Canadian regulators can rely on fewer animal tests without reducing safety – in fact, with modern data they often get more human-relevant, mechanistic insight. The 2021 Bhuller et al. perspective stresses that this shift positions PMRA for “the next generation of risk assessments”, where alternative non-animal strategies are fully built into decision-making.

Notably, Canada is not working alone. Health Canada is part of international collaborations (OECD, NAFTA-TWG with the US, Regulatory Cooperation Council, etc.) that set guidelines for NAMs and accept new methods globally. For example, NAFTA pesticide experts helped develop an OECD guidance on quantitative structure-activity relationships (QSAR) that PMRA now uses. This harmonization means that methods validated in Europe or the US can often be adapted for Canadian reviews. In short, PMRA’s next-gen risk assessment is a work in progress but is clearly accelerating.

Regulatory Transparency and Public Confidence

Even the most rigorous science can be met with suspicion if it happens behind closed doors. Transparency in pesticide regulation means giving the public understandable information on what’s approved, why, and how decisions were made. PMRA’s own policies emphasize stakeholder engagement and open science. For instance, key guidance documents (Data Protection, Technical Working Guidelines) are posted publicly for comment before being finalized. Many decision summaries for pesticide approvals are published on the PMRA website, including risk assessments and proposed regulatory text for new uses. These efforts signal a commitment to openness.

However, not everyone is convinced Canada’s pesticide regime is as transparent as it could be. In a recent CMAJ commentary, Gagnon and Bacon (2023) argued that “PMRA’s decision-making processes require much more transparency”. They pointed to the 2021 case where PMRA proposed doubling the maximum residue limits (MRLs) for glyphosate in some foods at the request of Monsanto. This proposal “raised serious concerns about the health impact” among scientists and the public. Critics noted that much of PMRA’s rationale and data for that decision remained confidential (CMAJ details “serious criticism for lack of transparency” around clinical data and business information). Although glyphosate is a chemical example, the point extends: if the public cannot scrutinize PMRA’s science or decisions, trust erodes.

For microbial biopesticides, transparency can also be tricky. The active strains or formulations are often proprietary. PMRA may certify a specific microbe strain to a product, but the detailed genetic or toxicology studies might be labeled Confidential Business Information (CBI) and withheld. This means, for instance, that researchers and local communicators (like extension officers in Winnipeg) may not see the full dataset behind an approval. Gagnon & Bacon’s suggestion – to improve transparency – implies making key information (risks, data summaries, decision rationale) more accessible without harming genuine trade secrets. As one witty EPA official put it, regulators should be like teachers: “explain why we trust it.”

Local pest-control businesses and homeowners also drive this demand. Winnipeggers learn from the media how agencies like the U.S. EPA handle biotech pests or drugs, and expect Health Canada’s PMRA to be similarly accountable. The call for “PMRA pesticide transparency” can translate into measures such as: publicly listing which microbial strains are approved and their conditions of use; explaining any data gaps or uncertainties; and holding open consultations on major decisions. These practices not only comply with Health Canada’s own open-government mandates, but they also align with the high value Manitobans place on environmental and health safety.

In summary, regulatory transparency is both a public relations and a policy issue. While PMRA has frameworks for disclosing science and inviting comments, external observers continue to press for more openness, especially when controversial approvals arise. An engaged regulatory regime – one that explains microbial pesticide risks and benefits clearly – ultimately makes risk assessment stronger by bringing in public insights and trust.

Winnipeg’s Take: Pest Control and Microbial Pesticides

Living in Winnipeg means enduring deep freezes and then facing a short but riotous pest season. Home gardens and lawns here see pests that survived the prairie winter burst back to life as soon as spring warms up the ground. Combatting these pests, from mosquitoes to weeds, increasingly involves discussing sustainable control methods. In the Canadian prairies, bacteria like B. thuringiensis are used against corn borers or mosquitoes; fungi such as Metarhizium species tackle grasshoppers; nematodes (tiny worms) can infect cutworm larvae in vegetable plots. Even if Manitoba’s -40°C cold seems lethal, these biocontrol organisms or their spores can overwinter effectively in soil or be reapplied.

By law, any such microbial agent must first clear the PMRA gauntlet. For example, a Bt product sold for residential mosquito control must be registered like any pesticide. The good news for Winnipeggers: PMRA’s risk assessment ensures that these products have minimal non-target effects (like avoiding fish or butterfly harm) before they land at the home center. The push towards next-generation risk assessments also means that new microbial products might face less cumbersome testing if scientific evidence (e.g. genomic safety data) shows they are safe for humans and pets.

For our local pest controller or homeowner, the bottom line is this: Canada’s rules are designed to let useful microbial pesticides onto the market and keep unsafe ones off. PMRA works with manufacturers to ensure products meet Canadian safety standards. At the same time, transparency efforts (public consultations, published decision summaries) give Manitobans a chance to voice any concerns. If, say, an exemption were proposed to allow a novel microbial spray for carpenter ants in the city, the PMRA would typically publish a notice and accept comments. This consultative process, allied with the agency’s adoption of modern testing methods, means Winnipegites can both benefit from cutting-edge biological pest controls and feel confident that the science is sound and open to scrutiny.

Conclusion

Microbial biopesticides, from Bacillus toxins to Beauveria fungi, offer Winnipeg homeowners and farmers safer ways to keep pests at bay. Canada’s regulatory system, led by the PMRA, is evolving to accommodate these products while ensuring strict safety standards. By embracing next-generation risk assessment methods (NAMs, AOPs, computational models, etc.), PMRA aims to make reviews both faster and more predictive of human and environmental health outcomes. At the same time, calls for regulatory transparency remind us that even the best science must be communicated clearly. Recent commentaries urge PMRA to improve how it shares data and decisions. In the end, a transparent, science-forward process means that when Winnipeg pest season arrives, the tools we use have been vetted thoroughly with our health and our lawns in mind. After all, in a town where we joke that spring arrives after Canada Day, people need a little reassurance: even if the bugs are late, they’re getting their final exams in safety evaluation here on time.

References

1. Bhuller, Y., Ramsingh, D., Beal, M., Kulkarni, S., Gagne, M., & Barton-Maclaren, T. S. (2021). Canadian regulatory perspective on next generation risk assessments for pest control products and industrial chemicals. Frontiers in Toxicology, 3, Article 748406. https://doi.org/10.3389/ftox.2021.748406
2. Bailey, K. L., Boyetchko, S. M., & Laengle, T. (2010). Social and economic drivers shaping the future of biological control: A Canadian perspective on the factors affecting the development and use of microbial biopesticides. Biological Control, 52(3), 221–229. https://doi.org/10.1016/j.biocontrol.2009.05.003
3. Gagnon, M.-A., & Bacon, M.-H. (2023). Time to improve transparency at Health Canada’s Pest Management Regulatory Agency. CMAJ, 195(46), E1583–E1584. https://doi.org/10.1503/cmaj.231089